Radiobiological and immunohistochemical assessment of hypoxia in human melanoma xenografts: acute and chronic hypoxia in individual tumours - PubMed (original) (raw)
Radiobiological and immunohistochemical assessment of hypoxia in human melanoma xenografts: acute and chronic hypoxia in individual tumours
E K Rofstad et al. Int J Radiat Biol. 1999 Nov.
Abstract
Purpose: Tumour hypoxia causes resistance to treatment and may promote the development of metastatic disease. The mean fraction of radiobiologically hypoxic cells has been determined for a large number of tumour cell lines, but quantitative information on intertumour heterogeneity in radiobiological hypoxia is sparse, and it is not known whether radiobiological hypoxia is mainly either chronic or acute in nature. The purpose of the work reported here was (1) to determine the fraction of radiobiologically hypoxic cells in individual tumours and (2) to differentiate quantitatively between chronic and acute hypoxia.
Materials and methods: Four human melanoma xenograft lines (A-07, D-12, R-18, U-25) were included. A radiobiological assay based on the paired survival curve method was established to measure the fraction of radiobiologically hypoxic cells. An immunohistochemical assay using the hypoxia marker pimonidazole was developed to determine the fraction of chronically hypoxic cells. The fraction of acutely hypoxic cells was estimated from the fraction of radiobiologically hypoxic cells and the fraction of chronically hypoxic cells.
Results: The fractions of radiobiologically hypoxic cells were in the ranges of 1-49% (A-07), 10-69% (D-12), 22-87% (R-18) and 23 85% (U-25); the fractions of chronically hypoxic cells were in the ranges of 0-15% (A-07), 5-25% (D-12), 4-17% (R-18) and 9-25% (U-25); the fractions of acutely hypoxic cells were in the ranges of 1-47% (A-07), 1-57% (D-12), 9-80% (R-18) and 5-69% (U-25). The fraction of acutely hypoxic cells was higher than the fraction of chronically hypoxic cells in most A-07, R-18 and U-25 tumours. The fraction of chronically hypoxic cells was higher than the fraction of acutely hypoxic cells in 16 of 25 D-12 tumours.
Conclusion: This study indicates that acute hypoxia in tumours is a far more serious problem than chronic hypoxia and, consequently, it may be beneficial to focus on acute hypoxia rather than chronic hypoxia when searching for clinically useful predictive assays of hypoxia-induced radiation resistance and malignant progression and for methods to overcome treatment resistance caused by hypoxia.
Similar articles
- Fluctuating and diffusion-limited hypoxia in hypoxia-induced metastasis.
Rofstad EK, Galappathi K, Mathiesen B, Ruud EB. Rofstad EK, et al. Clin Cancer Res. 2007 Apr 1;13(7):1971-8. doi: 10.1158/1078-0432.CCR-06-1967. Epub 2007 Mar 14. Clin Cancer Res. 2007. PMID: 17360973 - Detection of different hypoxic cell subpopulations in human melanoma xenografts by pimonidazole immunohistochemistry.
Gulliksrud K, Vestvik IK, Galappathi K, Mathiesen B, Rofstad EK. Gulliksrud K, et al. Radiat Res. 2008 Nov;170(5):638-50. doi: 10.1667/RR1400.1. Radiat Res. 2008. PMID: 18959463 - Radiation biology of malignant melanoma.
Rofstad EK. Rofstad EK. Acta Radiol Oncol. 1986 Jan-Feb;25(1):1-10. doi: 10.3109/02841868609136368. Acta Radiol Oncol. 1986. PMID: 3010642 Review. - [Radiation sensitizing agents for hypoxic cells: past, present and future].
Lartigau E. Lartigau E. Cancer Radiother. 1998 Dec;2(6):775-80. doi: 10.1016/s1278-3218(99)80022-5. Cancer Radiother. 1998. PMID: 9922787 Review. French.
Cited by
- Exogenous sickle erythrocytes combined with vascular disruption trigger disseminated tumor vaso-occlusion and lung tumor regression.
Sun CW, Wu LC, Wankhede M, Wang D, Thoerner J, Woody L, Sorg BS, Townes TM, Terman DS. Sun CW, et al. JCI Insight. 2019 Apr 4;4(7):e125535. doi: 10.1172/jci.insight.125535. eCollection 2019 Apr 4. JCI Insight. 2019. PMID: 30944254 Free PMC article. - Human cervical carcinoma xenograft models for studies of the physiological microenvironment of tumors.
Ellingsen C, Natvig I, Gaustad JV, Gulliksrud K, Egeland TA, Rofstad EK. Ellingsen C, et al. J Cancer Res Clin Oncol. 2009 Sep;135(9):1177-84. doi: 10.1007/s00432-009-0558-8. Epub 2009 Feb 13. J Cancer Res Clin Oncol. 2009. PMID: 19214568 - DCE-MRI of Tumor Hypoxia and Hypoxia-Associated Aggressiveness.
Gaustad JV, Hauge A, Wegner CS, Simonsen TG, Lund KV, Hansem LMK, Rofstad EK. Gaustad JV, et al. Cancers (Basel). 2020 Jul 20;12(7):1979. doi: 10.3390/cancers12071979. Cancers (Basel). 2020. PMID: 32698525 Free PMC article. Review. - Modeling acute and chronic hypoxia using serial images of 18F-FMISO PET.
Wang K, Yorke E, Nehmeh SA, Humm JL, Ling CC. Wang K, et al. Med Phys. 2009 Oct;36(10):4400-8. doi: 10.1118/1.3213092. Med Phys. 2009. PMID: 19928070 Free PMC article. - Photoacoustic imaging for the evaluation of early tumor response to antivascular treatment.
Yang J, Zhang G, Li Q, Liao C, Huang L, Ke T, Jiang H, Han D. Yang J, et al. Quant Imaging Med Surg. 2019 Feb;9(2):160-170. doi: 10.21037/qims.2018.11.06. Quant Imaging Med Surg. 2019. PMID: 30976540 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources